title: What Are the Costs of Corneal Cross-linking for the Treatment of Progressive Keratoconus?
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Godefrooij
authors.forename: Pepijn
authors.initials: P
authors.lastname: van Geuns
authors.forename: G Ardine
authors.initials: GA
authors.lastname: de Wit
authors.forename: Robert P L
authors.initials: RP
authors.lastname: Wisse
mesh_terms: D003094:Collagen / Q000378:metabolism; D003319:Corneal Stroma / Q000378:metabolism*; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D003432:Cross-Linking Reagents / Q000191:economics*; D016527:Drug Costs; D005260:Female; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D007640:Keratoconus / Q000188:drug therapy / Q000191:economics* / Q000378:metabolism; D008297:Male; D010778:Photochemotherapy / Q000191:economics*; D017319:Photosensitizing Agents / Q000191:economics; D012256:Riboflavin / Q000191:economics; D014466:Ultraviolet Rays; D014792:Visual Acuity / Q000502:physiology; D055815:Young Adult
chemical_list: D003432:Cross-Linking Reagents; D017319:Photosensitizing Agents; D003094:Collagen; D012256:Riboflavin